Physician profile
Annie Singh
NPI 1609466051
$13,824.63
in general payments reported to CMS, 2019-2025
25 companies · $2,711 in 2025
The $2,711 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $486 · 2022: $1,320 · 2023: $4,071 · 2024: $5,236 · 2025: $2,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,468.99 |
| Education | $549.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,045.24 | 2021-2025 | |
| Genzyme Corporation | $1,502.16 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $1,453.03 | 2023-2025 | Zoryve |
| Incyte Corporation | $1,451.46 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $1,372.30 | 2021-2025 | Dupixent |
| Lilly USA, LLC | $1,226.05 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $874.09 | 2023-2025 | Adbry |
| Janssen Biotech, INC. | $607.37 | 2023-2025 | Tremfya, Stelara |
| Sun Pharmaceutical Industries INC. | $550.49 | 2022-2025 | Winlevi, Absorica Ld |
| Ucb, INC. | $509.81 | 2023-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $504.58 | 2021-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $356.98 | 2021-2025 | Nemluvio, Aklief, Epsolay |
| Dermavant Sciences, INC. | $278.10 | 2023-2024 | Vtama |
| Almirall LLC | $267.36 | 2024-2025 | Klisyri, Seysara |
| Novartis Pharmaceuticals Corporation | $214.49 | 2021-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $144.04 | 2022 | |
| Allergan, INC. | $130.38 | 2022 | |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Pfizer INC. | $82.30 | 2024-2025 | |
| Organon LLC | $33.12 | 2025 | |
| Cipher Pharmaceuticals US LLC | $30.85 | 2025 | Spinosad, Natroba |
| Strata Skin Sciences, INC. | $27.41 | 2023 | Xtrac |
| Epi Health, LLC | $27.03 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.24 | 2025 | Cabtreo, Jublia, Siliq |
| Biofrontera INC. | $22.76 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.